# Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm

> **NCT03216473** · PHASE3 · COMPLETED · sponsor: **Medy-Tox** · enrollment: 140 (actual)

## Conditions studied

- Essential Blepharospasm

## Interventions

- **DRUG:** Neuronox
- **DRUG:** Botox

## Key facts

- **NCT ID:** NCT03216473
- **Lead sponsor:** Medy-Tox
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-25
- **Primary completion:** 2017-03-17
- **Final completion:** 2017-07-04
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2017-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03216473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03216473, "Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03216473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*